Navigation Links
Cannabis Science Provides Corporate Guidance on Preclinical Initiatives and Recent Corporate Developments for its Shareholders; CBIS Announces plans for 1st Q of 2013 Webinar Investor Call
Date:11/9/2012

patients with drug-resistant HIV strains, and those intolerant of currently available therapies. Cannabis Science will be pursuing a wide range of NIH based Federal Research Programs such as RO1's, PO1's and SBIRS which exist to support preclinical development of target validation and proof of concept studies. These studies will be implemented through collaborations with leading scientific institutions. Cannabis Science will also be pursuing other clinical research collaborations including the AIDS Clinical Trials Groups (ACTG), the Canadian AIDS Trial Network (CATN) and the European AIDS Trial Network (EATN).

About CS-S/BCC-1
Cannabis Science is currently working to develop preclinical investigations of CS-S/BCC-1 treatment of basal and squamous cell carcinomas. The Company has begun preclinical investigations, which are being initiated in Europe for Squamous/Basal Cell carcinomas and Kaposi's sarcoma based on inhibition of carcinogenicity utilizing cannabinoids that have been demonstrated in recent studies to significantly affect tumor necrosis.

About Cannabis Science, Inc.
Cannabis Science, Inc. is conducting cannabinoid research and development for unmet medical needs. The Company works with leading experts in HIV drug development, medicinal characterization, and clinical research to develop, produce, and commercialize Phytocannabinoid-based pharmaceutical products.  Cannabis Science is currently working with CBR International to develop a Pre-IND Application to the FDA that focuses on the use of CS-S/BCC-1 topical cannabis-based preparations for the treatment of basal and squamous cell carcinomas.

Forward Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar
'/>"/>

SOURCE Cannabis Science, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Rapid Fire Marketing: CANNAcig to Sponsor Medical Cannabis Cup 2012 in San Francisco
2. Cannabis Science Gets Set to Release "Phytiva" Its Newest Brand of Over-the-Counter Skin and Nutraceutical Product Lines Through its Newest Venture Phytiva Pharmaceuticals Inc.
3. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
4. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
5. Structural Trends to Profoundly Change Life Sciences Industry, Genpact Study Shows
6. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
7. Fuse Science Partners With GNC To Open National Distribution Of EnerJel™
8. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
9. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
10. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
11. Neurocrine Biosciences Reports First Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... N.C. , May 22, 2013 STEPh, ... to announce the launch of their web site ( ... [STEPh Reports].  About STEPh Reports ... in development.  Each STEPh Report assesses ... trials data, projected launch year, company, and specific key ...
(Date:5/22/2013)... INDEPENDENCE, Ohio , May 22, 2013   ... of health screening services announced today the creation of ... Health (MCM) . MCM is a ... services to MCM,s growing list of clients. These important ... in costly chronic conditions earlier. Effective prevention reduces cost ...
(Date:5/22/2013)...  Grifols, ein globales Unternehmen der Gesundheitsbranche ... , Spanien, präsentierte die Ergebnisse einer Studie, ... PROLASTIN©-C (Alpha1-Proteinasehemmer [human]) den Spiegel des Alpha1-Proteins ... Niveau anhebt, das innerhalb des für gesunde ... eine lebensbedrohliche, genetische Erkrankung, bei der der ...
Breaking Medicine Technology:Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site 2Life Line Screening and MCM Solutions for Better Health Announce New Partnership 2Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 2Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 3Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 4
... Ind., Feb. 14, 2012  Heraeus Kulzer, LLC, the worldwide ... Metal Refining Division donated almost $20,000 to the ... A non-profit organization founded in 2008 with ... Laboratories (NADL), FDLT,s purpose is to advance the profession ...
... 14, 2012 SCOLR Pharma, Inc. (OTCQB: SCLR) announced ... had previously obtained the exclusive worldwide rights to use ... ondansetron, will conduct a bioequivalence trial in Canada.  Both ... Canada have reviewed the protocol for the study and ...
Cached Medicine Technology:Heraeus' Precious Metal Refining Division Donates Nearly $20,000 to Foundation for Dental Laboratory Technology 2Heraeus' Precious Metal Refining Division Donates Nearly $20,000 to Foundation for Dental Laboratory Technology 3Heraeus' Precious Metal Refining Division Donates Nearly $20,000 to Foundation for Dental Laboratory Technology 4SCOLR Pharma's Partner to Commence Bioequivalence Study of Ondansetron 2SCOLR Pharma's Partner to Commence Bioequivalence Study of Ondansetron 3
(Date:5/23/2013)... 2013 Shirataki noodles are ... part of a diet strategy. These noodles are originally ... konjac plant. When losing weight, diet and exercise are ... website helping dieters not only research shirataki noodles but ... where to buy them. Shirataki noodles are ...
(Date:5/23/2013)... GBI Research’s analysis indicates that the global ... small number of players accounting for a major proportion of ... growth rate between 2006 and 2012, possibly due to the ... markets, especially in the US. , GBI Research estimates ... billion in 2012, having grown in size at a CAGR ...
(Date:5/22/2013)... Prairie, WI (PRWEB) May 23, 2013 ... , introduced a new feature to its website ... from the agency’s client portfolio through an immersive, 360-degree, ... clients and prospective customers the ability to virtually experience ... a developer of medical technologies and services. Users have ...
(Date:5/22/2013)... CA (PRWEB) May 22, 2013 Dr. Andrew ... to painful scalpel surgery with the Laser Assisted New Attachment ... is raising awareness about the connections between gum disease and ... concerns in the United States today, and is linked to ... of bacteria found in the infected gum pockets. , ...
(Date:5/22/2013)... 2013 Hosted by the California Dental ... clinic provided more than $1.6 million in charitable dental ... San Jose. , The California Dental Association Foundation ... provide free dental services and oral health education to ... third clinic held by CDA and CDAF in the ...
Breaking Medicine News(10 mins):Health News:DietNoodleShop.com is Re-launching; Adding More Diet Recipes Along with Information on Shirataki Noodles 2Health News:MarketResearch.com Report – Increased Cost of Albumin was Main Factor for Double-Digit Growth of Global Critical Care Market Between 2006 and 2012 2Health News:Catalyst Exhibits Debuts 360 Degree Virtual Tour of St. Jude Medical Trade Show Booth 2Health News:For Stroke Awareness Month, Dr. Andrew Satlin is Raising Awareness of the Connections Between Gum Disease and Stroke and Offers Encino, CA Laser Gum Surgery for Treatment 2Health News:Two-day San Jose Dental Clinic Provides More Than $1.6 Million in Care 2
... N.Y. -- Vietnam War-era veterans exposed to Agent Orange ... disorder, than veterans with no exposure, a new study ... Ajay Varanasi, MD, an endocrinology fellow in ... the study, garnered first prize in the oral presentation ...
... one of the world,s deadliest diseases may lie within ... of Central Florida scientist Debopam Chakrabarti is analyzing more ... sea near Florida,s coast. Some of them could hold ... mosquito-borne illness that kills more than 1 million people ...
... University of Leicester is set to play a vital role ... many families find to be unpleasant. The research team ... has won a substantive award by the National Institute for ... cardiac angiography in relation to near virtual autopsies. ...
... A ... on losing weight. It looks at how ephedrine products affect the body,s energy levels, control ... ... article that examines ephedrine HCL and its effects on weight loss. This article, entitled " ...
... To ... or 202.684.3728. , ... (Vocus) June 28, 2010 -- With the deadline fast approaching for new federal rules implementing ... has sent a letter, also signed by many of his colleagues, to the Departments of ...
... HealthDay Reporter , SUNDAY, June 27 (HealthDay News) -- ... gain greater blood sugar control overnight, even when they have ... The promise of this emerging technology is to free diabetics ... by letting a computer program do the job -- constantly ...
Cached Medicine News:Health News:Agent Orange exposure linked to Graves' disease in Vietnam veterans, UB study finds 2Health News:Underwater sponges and worms may hold key to cure for malaria 2Health News:New Article Re-Examines Ephedrine HCL Products For Weight Loss 2Health News:National Council Applauds Rep. Tonko for Seeking Strict Enforcement of Mental Health Parity Law – July 1, 2010 Deadline Approaching 2Health News:Artificial Pancreas Continues to Show Promise 2Health News:Artificial Pancreas Continues to Show Promise 3Health News:Artificial Pancreas Continues to Show Promise 4
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
... and value!, Comfortable feel and ... contoured handle , Finer control while ... action , Completely autoclavable for easy ... for recalibration , Easy-to-read precision micrometer ...
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
... the specialty areas of cardiac ... care work, it is essential ... practice. Alokas motorized TEE transducer ... Tissue Harmonic Echo technology allows ...
Medicine Products: